89Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: Implications for future cancer therapy

Linda Karmani, Virginie Bouchat, Caroline Bouzin, Philippe Levêque, Daniel Labar, Anne Bol, Gladys Deumer, Riccardo Marega, Davide Bonifazi, Vincent Haufroid, Carine Michiels, Vincent Grégoire, Olivier Feron, Stéphane Lucas, Thierry Vander Borght, Bernard Gallez

Research output: Contribution to journalArticlepeer-review

4 Downloads (Pure)

Fingerprint

Dive into the research topics of '89Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: Implications for future cancer therapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology